𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease

✍ Scribed by Cantillon, Marc; Brunswick, Roger; Molina, David; Bahro, Marcel

Book ID
123482658
Publisher
American Psychiatric Publishing Inc
Year
1996
Tongue
English
Weight
860 KB
Volume
4
Category
Article
ISSN
1064-7481

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A 6-month, randomized, double-blind, pla
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease
✍ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 215 KB πŸ‘ 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha

Ergot mesylates for alzheimer's disease:
Ergot mesylates for alzheimer's disease: A year-long double-blind trial of 3 mg vs 12 mg daily
✍ Michael A. Jenike; Marilyn Albert; Lee Baer; Jeanette Gunther; Christine Corvino πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 543 KB

Of 25 patients who entered a year-long double-blind comparison study of high (12 mg/day) versus low (3 mg/day) dosages of ergot mesylates (Hydergine), 17 completed the full year of study and no patients suffered problematic side-effects. On a number of complex tests of memory function, there was no